Point72 Asset Management
MRVI icon

Point72 Asset Management’s Maravai LifeSciences MRVI Stock Holding History

Point72 Asset Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5M Sell
2,005,579
-1,199,917
-37% -$5.18M 0.01% 1145
2026
Q1 		$9.07M Buy
3,205,496
+357,697
+13% +$1.21M 0.01% 1314
2025
Q4 		$9.26M Buy
2,847,799
+2,815,057
+8,598% +$9.48M 0.01% 1405
2025
Q3 		$94K Buy
+32,742
New +$83.6K ﹤0.01% 2211
2024
Q4 		– Sell
-1,026,749
Closed -$8.53M – 2314
2024
Q3 		$8.53M Sell
1,026,749
-2,492,812
-71% -$21.5M 0.02% 698
2024
Q2 		$25.2M Buy
3,519,561
+2,109,199
+150% +$18.2M 0.07% 344
2024
Q1 		$12.2M Buy
1,410,362
+459,162
+48% +$3.11M 0.03% 643
2023
Q4 		$6.23M Buy
+951,200
New +$6.15M 0.02% 844
2023
Q3 		– Sell
-460,111
Closed -$5.72M – 2731
2023
Q2 		$5.72M Buy
+460,111
New +$6.21M 0.02% 769
2022
Q4 		– Sell
-151,000
Closed -$3.85M – 1694
2022
Q3 		$3.85M Buy
+151,000
New +$3.79M 0.02% 794
2022
Q1 		– Sell
-390,900
Closed -$13.1M – 1307
2021
Q4 		$16.4M Buy
390,900
+261,412
+202% +$10.6M 0.07% 379
2021
Q3 		$6.36M Buy
+129,488
New +$6.32M 0.03% 608
2021
Q1 		– Sell
-493,883
Closed -$13.9M – 1099
2020
Q4 		$13.9M Buy
+493,883
New +$13.8M 0.07% 366

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Point72 Asset Management's MRVI Position: Q2 2026 in Review

Point72 Asset Management reduced its Maravai LifeSciences (MRVI) stake by 37% in Q2 2026, selling an estimated $5.18M and leaving 2,005,579 shares worth $12.5M. The position accounts for 0.01% of the portfolio, ranked #1145.

Point72 Asset Management first reported a position in MRVI in Q4 2020 and has held it in 13 quarters since. The position peaked at $25.2M in Q2 2024. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Point72 Asset Management held 2,005,579 shares of Maravai LifeSciences worth $12.5M as of Q2 2026.
  • Point72 Asset Management sold 1,199,917 Maravai LifeSciences shares in Q2 2026, an estimated $5.18M.
  • Maravai LifeSciences made up 0.01% of Point72 Asset Management's portfolio in Q2 2026, its #1145 holding.
  • Point72 Asset Management first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 13 quarters since.
  • Point72 Asset Management's Maravai LifeSciences position peaked at $25.2M in Q2 2024.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.